- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04567342
Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of MMR Vaccination
October 12, 2021 updated by: Children's Hospital Medical Center, Cincinnati
Our objective is to determine the effectiveness of varied outreach methods (e.g.
automated reminder calls/text messages with or without personalized calls/texts) to children age 12-14 months or 4 years old who are due for a WCC visit and don't have one scheduled in the next 45 days on the outcomes of appointment scheduling, appointment completion, and receipt of the MMR vaccination.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
1312
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229-3039
- Cincinnati Children's Hospital Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 4 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age: 12-14 months old OR 4 years old
- Has not yet received first MMR (for 12-14 month olds) OR second MMR (for 4 year olds)
- Has not had a well child check in past 365 days (for 4 year olds)
- No appointment scheduled in the next 45 days
- Parent preferred language = English or Spanish
Exclusion Criteria:
- Phone number not available in electronic medical record
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arm 1
|
Parents of eligible patients will receive 1 HIPAA compliant automated call or text reminder (based on preference recorded in EHR) that their child is due for a checkup and information on how to schedule an appointment.
No personal contact attempts will be made.
|
Experimental: Arm 2
|
No personal contact attempts will be made.
Parents of eligible patients will receive 2 HIPAA compliant automated call or text reminders (based on preference recorded in EHR) that their child is due for a checkup and information on how to schedule an appointment.
|
Experimental: Arm 3
|
Parents of eligible patients will receive 1 HIPAA compliant automated call or text reminder (based on preference recorded in EHR) that their child is due for a checkup and information on how to schedule an appointment.
Parents of eligible patients will receive a text from a medical assistant informing them that their child is due for a check up.
This will be followed by personal call from the medical assistant to assist the parent with scheduling an appointment.
|
Experimental: Arm 4
|
Parents of eligible patients will receive 2 HIPAA compliant automated call or text reminders (based on preference recorded in EHR) that their child is due for a checkup and information on how to schedule an appointment.
Parents of eligible patients will receive a text from a medical assistant informing them that their child is due for a check up.
This will be followed by personal call from the medical assistant to assist the parent with scheduling an appointment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Receipt of MMR vaccination
Time Frame: By 15 months of age (for children who are 12-14 months old), or within 3 months of receiving intervention (for children age 4 years old)
|
MMR administered to child (Yes or No) based on electronic health record documentation
|
By 15 months of age (for children who are 12-14 months old), or within 3 months of receiving intervention (for children age 4 years old)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Appointment scheduled
Time Frame: Within 2 weeks of receiving intervention
|
Appointment scheduled (Yes or No) based on electronic health record documentation
|
Within 2 weeks of receiving intervention
|
Appointment completed
Time Frame: Within 8 weeks of receiving intervention
|
Appointment completed (Yes or No) based on electronic health record documentation
|
Within 8 weeks of receiving intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: William B Brinkman, MD, Cincinnati Children's
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 27, 2020
Primary Completion (Actual)
August 6, 2021
Study Completion (Actual)
September 5, 2021
Study Registration Dates
First Submitted
September 23, 2020
First Submitted That Met QC Criteria
September 23, 2020
First Posted (Actual)
September 28, 2020
Study Record Updates
Last Update Posted (Actual)
October 13, 2021
Last Update Submitted That Met QC Criteria
October 12, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-0769
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health Care Utilization
-
Finnish Institute for Health and WelfareCompletedHealth Behavior | Health Care Utilization | Health Care Seeking BehaviorFinland
-
University of CalgaryUniversity of British Columbia; Canadian Institutes of Health Research (CIHR); Alberta Health servicesRecruitingUtilization, Health CareCanada
-
Victoria D. OjedaNational Institute on Minority Health and Health Disparities (NIMHD)Recruiting
-
Elizabeth K RhodusRecruiting
-
Children's Mercy Hospital Kansas CityCompleted
-
Geisinger ClinicCompleted
-
University Hospital, BordeauxCompleted
-
Seattle Children's HospitalCompleted
-
Children's Hospital Medical Center, CincinnatiCompletedEffect of Varied Outreach Methods on Appointment Scheduling and Appointment Completion Using MyChartHealth Care UtilizationUnited States
-
University of ArkansasRecruiting
Clinical Trials on 1 automated message
-
Emory UniversityCompleted
-
Stanford UniversityCompleted
-
VA Puget Sound Health Care SystemNot yet recruiting
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
The University of Hong KongRecruitingStroke | Hypertension | Lifestyle ModificationsHong Kong
-
Kessler FoundationUnknownStroke | Cognitive Impairment | Brain Injuries, Traumatic | Medication Adherence | Stroke, Acute | Medication ComplianceUnited States
-
Columbia UniversityNational Cancer Institute (NCI); Makerere UniversityNot yet recruiting
-
Click Therapeutics, Inc.CompletedCovid19 | Stress | Stress, Psychological | LonelinessUnited States
-
Thomas Jefferson UniversityCompletedChronic Phase Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Columbia UniversityCompleted